New Partnership between Neurotrack and Midi Health Streamlines Cognitive Assessment for Women’s Health

Midi Health teams up with Neurotrack to assist in detecting cognitive decline during menopause.

Neurotrack, a digital cognitive assessment company, is joining forces with Midi Health, a clinic specializing in midlife women’s health. Through this collaboration, Midi Health clinicians can administer Neurotrack’s cognitive screening to patients via smartphone, tablet or computer, significantly reducing the time it takes to complete the test to just three minutes.

Patients who receive low scores on the Neurotrack screening will be referred to healthcare providers for a more detailed evaluation. This partnership aims to provide women with timely and accurate information about their cognitive health, allowing for early detection and intervention if necessary. According to Midi Health’s Chief Medical Officer, Kathleen Jordan, brain fog is a common symptom reported by 74% of their patients going through menopause. However, she notes that experiencing brain fog does not necessarily indicate a higher risk of developing dementia. For most women, the Neurotrack screening can offer reassurance but for a few it could lead to early detection of dementia which benefits from early treatment.

Midi Health recently secured $25 million in Series A funding led by Google Ventures to expand its services across the country. Neurotrack based in Silicon Valley raised $10 million in 2022 and has been actively partnering with organizations like insurance provider Nationwide to streamline cognitive health assessments for long-term care underwriting. The collaboration between Midi Health and Neurotrack highlights the importance of early cognitive assessment in women’s health particularly during the menopausal transition. By leveraging digital technologies these companies are making it easier for women to access timely and accurate information about their cognitive well-being ultimately improving outcomes for those at risk of cognitive decline.

Leave a Reply